Diversity of sea bass pathogen strains highlights challenge in Mediterranean aquaculture
A new study analyzing three strains of the bacterium Vibrio harveyi found among farmed sea bass in the Mediterranean has underlined the diversity of the pathogen, which poses a severe threat to the region’s aquaculture.
Sea bass & sea bream
No effective licensed therapies exist against amyloodiniosis, a disease of fish species caused by Amyloodinium ocellatum (AO) ectoparasites. However, new research has shown that European sea bass (ESB) can develop specific immunity to the disease, which could in turn lead to the development of vaccines.
With technologies for molecular diagnosis of fish disease increasingly available, sometimes simpler approaches that have great diagnostic power are being ignored.
Improving standards on Mediterranean fish farms is driving interest in Tricaine PHARMAQ — the only authorized fish anesthetic product.
Aquaculture in Greece has endured some ups and downs since its establishment in the 1980s, from the Greek financial crisis to the Covid-19 pandemic.
Barramundi has much potential as a sustainable fish in the marine tropics — but health challenges remain for producers. Josh Goldman, CEO of Australis, explains his company’s approach.
European sea bass aquaculture is centered on the Mediterranean basin, and there are a number of notable pathogens which can cause high mortality on production sites through direct and indirect effects.